All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| CGON / CG Oncology, Inc.
|
|
|
|
|
|
|
|
| BSX / Boston Scientific Corporation
|
|
|
|
|
|
|
|
| NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
| ELVN / Enliven Therapeutics, Inc.
|
|
|
|
|
|
|
|
| IMUX / Immunic, Inc.
|
|
|
|
|
|
|
|
| ORKA / Oruka Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| MCK / McKesson Corporation
|
|
|
|
|
|
|
|
| NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| PVLA / Palvella Therapeutics, Inc.
|
|
|
|
|
|
|
|
| PFE / Pfizer Inc.
|
|
|
|
|
|
|
|
| RGEN / Repligen Corporation
|
|
|
|
|
|
|
|
| CI / The Cigna Group
|
|
|
|
|
|
|
|
| TMO / Thermo Fisher Scientific Inc.
|
|
|
|
|
|
|
|
| WAT / Waters Corporation
|
|
|
|
|
|
|
|
| PHAT / Phathom Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| GMAB / Genmab A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ICLR / ICON Public Limited Company
|
|
|
|
|
|
|
|
| JBIO / Jade Biosciences, Inc.
|
|
|
|
|
|
|
|
| CATX / Perspective Therapeutics, Inc.
|
|
|
|
|
|
|
|
| KPTI / Karyopharm Therapeutics Inc.
|
|
|
|
|
|
|
|
| MDT / Medtronic plc
|
|
|
|
|
|
|
|
| CORT / Corcept Therapeutics Incorporated
|
|
|
|
|
|
|
|
| EHC / Encompass Health Corporation
|
|
|
|
|
|
|
|
| KVUE / Kenvue Inc.
|
|
|
|
|
|
|
|
| MTSR / Metsera, Inc.
|
|
|
|
|
|
|
|
| TMO / Thermo Fisher Scientific Inc.
|
|
|
|
|
|
|
|
| CARL / Carlsmed, Inc.
|
|
|
|
|
|
|
|
| EXAS / Exact Sciences Corporation
|
|
|
|
|
|
|
|
| BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
| INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
| DHR / Danaher Corporation
|
|
|
|
|
|
|
|
| BEAM / Beam Therapeutics Inc.
|
|
|
|
|
|
|
|
| ACHC / Acadia Healthcare Company, Inc.
|
|
|
|
|
|
|
|
| A / Agilent Technologies, Inc.
|
|
|
|
|
|
|
|
| ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| COR / Cencora, Inc.
|
|
|
|
|
|
|
|
| CNC / Centene Corporation
|
|
|
|
|
|
|
|
| DHR / Danaher Corporation
|
|
|
|
|
|
|
|
| HQY / HealthEquity, Inc.
|
|
|
|
|
|
|
|
| INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
| ITGR / Integer Holdings Corporation
|
|
|
|
|
|
|
|
| IQV / IQVIA Holdings Inc.
|
|
|
|
|
|
|
|
| WVE / Wave Life Sciences Ltd.
|
|
|
|
|
|
|
|
| PFE / Pfizer Inc.
|
|
|
|
|
|
|
|
| ARQT / Arcutis Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| MCK / McKesson Corporation
|
|
|
|
|
|
|
|
| IMRX / Immuneering Corporation
|
|
|
|
|
|
|
|
| UNH / UnitedHealth Group Incorporated
|
|
|
|
|
|
|
|
| HQY / HealthEquity, Inc.
|
|
|
|
|
|
|
|
| ASND / Ascendis Pharma A/S
|
|
|
|
|
|
|
|
| COR / Cencora, Inc.
|
|
|
|
|
|
|
|
| XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| ARVN / Arvinas, Inc.
|
|
|
|
|
|
|
|
| CI / The Cigna Group
|
|
|
|
|
|
|
|
| AKRO / Akero Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ABBV / AbbVie Inc.
|
|
|
|
|
|
|
|
| JNJ / Johnson & Johnson
|
|
|
|
|
|
|
|
| CNTX / Context Therapeutics Inc.
|
|
|
|
|
|
|
|
| SCYX / SCYNEXIS, Inc.
|
|
|
|
|
|
|
|
| DNTH / Dianthus Therapeutics, Inc.
|
|
|
|
|
|
|
|
